Alexander Breskin

Regeneron Pharmaceuticals, Inc., United States

Disclosure information not submitted.

Presentation(s):

• 1F-04 - Prevalence of Major Congenital Malformations Identified Using Diagnosis Codes Among Live-Born Infants in a US Commercial Claims Database

  Sunday, August 24, 2025
  11:15 AM - 11:30 AM ET

• 2D-03 - Mind the gap: a simulation study to compare definitions of treatment discontinuation

  Sunday, August 24, 2025
  3:40 PM - 3:45 PM ET

• 4E-04 - Bigger is better: replicating a signal detection study using tree-based scan statistics in two real world data sources

  Monday, August 25, 2025
  5:00 PM - 5:15 PM ET

• 5B-04 - To Clone or Not to Clone? Baseline Incompatibility with Regimens when Cloning, Censoring, and Weighting

  Tuesday, August 26, 2025
  9:15 AM - 9:30 AM ET

• 5B-05 - The Dangers of Stabilizing Censoring Weights

  Tuesday, August 26, 2025
  9:30 AM - 9:45 AM ET